Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
DATA GRAPHICS | Finance

Valuations spiral into billions as trio of IPOs post big aftermarket gains: Data Byte

March 26, 2021 8:33 PM UTC

Design Therapeutics became the latest preclinical company to score a billion-dollar valuation as it went public ahead of Friday’s session, and its shares more than doubled in value during the day.

The company was one of three biopharmas to go public ahead of trading Friday, alongside Edgewise Therapeutics Inc. (NASDAQ:EWTX) and Ikena Oncology Inc. (NASDAQ:IKNA), both of which also rose sharply in value amid high demand...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article